Clinical trial
HIBOC = Hepatic Imaging Biomarkers in Obese Children
Invitation only · Not applicable · 1 countries · Registry ID NCT06463223
What this study is about
The goal of this prospective, diagnostic observational study is to learn about how imaging based markers for components of liver disease appear in children with obesity. It aims to determine whether the imaging markers (ultrasound and MRI) for liver disease can be tools to improve diagnostics for liver affection in children with obesity and to ascertain how the markers are related to multiple clinical measures, for example BMI and serology measure, and treatment effects over time.
Basic eligibility
Full registry criteria
Treatments and study arms
Primary outcomes
an ultrasound based measure of steatosis in the liver
an ultrasound based estimation of increased liver viscosity, seen in for example inflammation
an ultrasound based measure of liver stiffness as a reflection of liver fibrosis
Study locations
1 locations were listed when this page was built. The first 40 are shown.